The virtual study, which included wearable data from more than 30,500 participants, found that changes in sleep, activity and heart rate levels, along with self-reported symptom data, could be used to identify potential cases of Covid-19.
Scripps Research launched a new study to see if data collective from wearable devices could be used to track flu-like illnesses, including Covid-19. In January, Scripps published a retrospective study using a similar methodology showing that sleep and resting heart rate data from Fitbits were correlated with the number of patients reporting influenza-like illness.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
A new study by the Scripps Research Translational Institute suggests Fitbits could be used to detect the flu. By tracking resting heart rate and activity levels, researchers said Fitbits could improve detection of outbreaks at the state level.
The National Center for Advancing Translational Sciences has awarded Johns Hopkins University School of Medicine, Oregon Health & Science University, Northwestern University and others a five-year, $25 million agreement to develop the CD2H.
A startup from the Scripps Research Institute has raised a $50 million Series A to "expand the druggable proteome." Led by ARCH and Versant Ventures, the sizeable investment reflects the potential of both the platform and the countless therapeutic candidates it could produce.
Researcher Erica Ollmann Saphire is getting sent Ebola samples faster than she can process them at her Scripps Research Institute lab, the San Diego Union-Tribune reports, so she’s turned to crowdfunding to raise the $100,000 she needs to buy better instruments. Saphire’s behind the global consortium of researchers that developed the experimental ZMapp serum, the drug […]
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.